Dr. Jinzhong Lin is a Professor at Fudan University, where he leads the Fudan Center for mRNA Translational Research and the Shanghai Zhangjiang mRNA Innovation and Translation Center. He earned his Ph.D. in biophysics from the Chinese Academy of Sciences and completed postdoctoral training at Yale University under Nobel laureate Thomas Steitz. Since returning to China in 2017, Dr. Lin has made significant contributions to the field of mRNA translation regulation, establishing the country’s first mRNA drug development center at Fudan University. His research has driven key advancements in mRNA capping, modification, and delivery technologies. Dr. Lin played a pivotal role in developing China’s first mRNA COVID-19 vaccine, which successfully completed Phase III clinical trials and received emergency use authorization. This milestone marks the first university-led mRNA vaccine in China. Dr. Lin has authored over 60 high-impact research articles, contributing significantly to the advancement of mRNA science.
Jinzhong Lin
